A comparison of the effects of a chlamydial vaccine administered during or after a C. muridarum urogenital infection of female mice

被引:4
作者
Carey, Alison [1 ]
Cunningham, Kelly [1 ]
Andrew, Dean [1 ]
Hafner, Louise [1 ]
Timms, Peter [1 ]
Beagley, Kenneth [1 ]
机构
[1] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia
基金
英国医学研究理事会;
关键词
Chlamydia; Pathology; Timing of vaccination; GENITAL-TRACT INFECTION; NECROSIS-FACTOR-ALPHA; TRANSCUTANEOUS IMMUNIZATION; TRACHOMATIS INFECTION; PROTECTIVE IMMUNITY; DENDRITIC CELLS; INVIVO; LIVE; MONKEYS; ANTIGEN;
D O I
10.1016/j.vaccine.2011.07.012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Research into an efficacious Chlamydia trachomatis vaccine is ongoing, however, there has been no examination into the timing of vaccine administration to either asymptomatically or previously infected individuals. Using the female Chlamydia muridarum genital tract mouse model, we examined this aspect of vaccine development. Our results show timing of vaccination affected the production of systemic antibodies, but had minimal effects on mucosal antibody production. Vaccination during an active infection or after a resolved infection did not provide protection against re-exposure to Chlamydia, and did not exacerbate the development of pathological sequelae in infected mice. This demonstrates that vaccination may not be protective in individuals who are seropositive for an acute or previous chlamydial infection. Crown Copyright (C) 2011 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:6505 / 6513
页数:9
相关论文
共 42 条
  • [31] Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection
    Skelding, KA
    Hickey, DK
    Horvat, JC
    Bao, SS
    Roberts, KG
    Finnie, JM
    Hansbro, PM
    Beagley, KW
    [J]. VACCINE, 2006, 24 (03) : 355 - 366
  • [32] Glycoprotein-D-adjuvant vaccine to prevent genital herpes
    Stanberry, LR
    Spruance, SL
    Cunningham, AL
    Bernstein, DI
    Mindel, A
    Sacks, S
    Tyring, S
    Aoki, FY
    Slaoui, M
    Denis, M
    Vandepapeliere, P
    Dubin, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (21) : 1652 - 1661
  • [33] The cellular paradigm of chlamydial pathogenesis
    Stephens, RS
    [J]. TRENDS IN MICROBIOLOGY, 2003, 11 (01) : 44 - 51
  • [34] Responses of varicella zoster virus (VZV)-specific immunity in seropositive adults after inhalation of inactivated or live attenuated varicella vaccine
    Terada, K
    Niizuma, T
    Ogita, S
    Kataoka, N
    [J]. VACCINE, 2002, 20 (31-32) : 3638 - 3643
  • [35] TOTH M, 1992, SURG GYNECOL OBSTET, V174, P359
  • [36] Development of therapeutic HPV vaccines
    Trimble, Cornelia L.
    Frazer, Ion H.
    [J]. LANCET ONCOLOGY, 2009, 10 (10) : 975 - 980
  • [37] TRACHOMA VACCINE STUDIES IN MONKEYS
    WANG, SP
    GRAYSTON, JT
    ALEXANDE.ER
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1967, 63 (5P2) : 1615 - &
  • [38] PANNUS WITH EXPERIMENTAL TRACHOMA AND INCLUSION CONJUNCTIVITIS AGENT INFECTION OF TAIWAN MONKEYS
    WANG, SP
    GRAYSTON, JT
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1967, 63 (5P2) : 1133 - &
  • [39] A ROLE INVIVO FOR TUMOR NECROSIS FACTOR-ALPHA IN HOST DEFENSE AGAINST CHLAMYDIA-TRACHOMATIS
    WILLIAMS, DM
    MAGEE, DM
    BONEWALD, LF
    SMITH, JG
    BLEICKER, CA
    BYRNE, GI
    SCHACHTER, J
    [J]. INFECTION AND IMMUNITY, 1990, 58 (06) : 1572 - 1576
  • [40] World Health Organization, 2012, GLOB PREV INC SEL CU